QT Imaging (NASDAQ:QTI – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.11), Zacks reports.
QT Imaging Price Performance
NASDAQ:QTI traded down $0.96 during trading hours on Wednesday, hitting $6.63. 67,549 shares of the stock traded hands, compared to its average volume of 37,351. The company has a quick ratio of 2.17, a current ratio of 2.81 and a debt-to-equity ratio of 0.71. QT Imaging has a 1 year low of $0.65 and a 1 year high of $8.50. The company has a market cap of $79.84 million, a price-to-earnings ratio of -3.03 and a beta of 0.01. The stock has a 50 day moving average price of $6.59 and a 200 day moving average price of $6.14.
Analyst Ratings Changes
QTI has been the topic of several recent analyst reports. Zacks Research raised shares of QT Imaging from a “strong sell” rating to a “hold” rating in a research report on Monday, April 20th. Lake Street Capital began coverage on shares of QT Imaging in a report on Friday, January 30th. They set a “buy” rating on the stock. Finally, Weiss Ratings began coverage on shares of QT Imaging in a report on Thursday, January 29th. They set a “sell (e+)” rating on the stock. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, QT Imaging currently has an average rating of “Hold”.
QT Imaging Company Profile
QT Imaging Ltd. (NASDAQ: QTI) is a medical technology company specializing in the development and commercialization of advanced ultrasound imaging solutions. The company focuses on real-time volumetric imaging systems designed to enhance diagnostic capabilities in obstetrics, gynecology and other clinical applications. QT Imaging’s flagship Q.VIEW® system and associated software suite enable practitioners to capture, analyze and visualize high-resolution 3D/4D ultrasound images, offering improved workflow efficiency and enhanced patient care.
QT Imaging’s product portfolio includes proprietary transducers, imaging consoles and software platforms that can be integrated with existing ultrasound scanners from leading original equipment manufacturers.
See Also
- Five stocks we like better than QT Imaging
- D-Wave Earnings Looked Weak, But Investors May Be Missing This
- Nebius Upside Expands as AI Feedback Loop Intensifies
- Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell
- Plug Power Flips The Switch On Profitability
Receive News & Ratings for QT Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QT Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
